BOTTICELLI, ANNIBALE RENZO
 Distribuzione geografica
Continente #
NA - Nord America 120
AS - Asia 88
EU - Europa 34
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 271
Nazione #
US - Stati Uniti d'America 114
SG - Singapore 40
BR - Brasile 20
CN - Cina 17
VN - Vietnam 13
IT - Italia 8
IN - India 7
SE - Svezia 6
GB - Regno Unito 5
PL - Polonia 4
CA - Canada 3
IQ - Iraq 3
MX - Messico 3
RU - Federazione Russa 3
AR - Argentina 2
CY - Cipro 2
EC - Ecuador 2
ES - Italia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
DE - Germania 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
NL - Olanda 1
NO - Norvegia 1
PH - Filippine 1
SA - Arabia Saudita 1
SN - Senegal 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 271
Città #
San Jose 24
Ashburn 16
Singapore 16
Dallas 10
Santa Clara 8
Bengaluru 7
Hefei 7
Princeton 7
Lawrence 6
Milan 6
Beijing 4
Hanoi 4
Chicago 3
Des Moines 3
Ho Chi Minh City 3
New York 3
Baghdad 2
Guayaquil 2
Kyrenia 2
London 2
Norwalk 2
Phoenix 2
Poznan 2
Stockholm 2
Anápolis 1
Apodaca 1
Birmingham 1
Bismarck 1
Biên Hòa 1
Boston 1
Bragança Paulista 1
Buffalo 1
Cabo de Santo Agostinho 1
Campinas 1
Canoas 1
Charlotte 1
Clearwater 1
Cuiabá 1
Curitiba 1
Córdoba 1
Da Nang 1
Dakar 1
Dammam 1
Formosa 1
Francisco Morato 1
Frederico Westphalen 1
Hong Kong 1
Hải Dương 1
Ijuí 1
Irecê 1
Jakarta 1
Jaú 1
Lesosibirsk 1
Linhares 1
Los Angeles 1
Montreal 1
Najaf 1
Nuremberg 1
Pisa 1
Praia Grande 1
Providence 1
Quezon City 1
Raleigh 1
Ribeirão Preto 1
Rio de Janeiro 1
San Francisco 1
Sirinhaém 1
St Petersburg 1
Sugar Land 1
São José dos Campos 1
Tancítaro 1
Tashkent 1
Thuận An 1
Votorantim 1
Vĩnh Tường 1
Warsaw 1
West Covina 1
Zurich 1
Totale 197
Nome #
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study 53
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 53
Role of chemotherapy in vulvar cancers: Time to rethink standard of care? 42
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors 36
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 36
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes 34
Neoadjuvant immune-checkpoint blockade in triple-negative breast cancer: Current evidence and literature-based meta-analysis of randomized trials 31
Totale 285
Categoria #
all - tutte 3.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 0 0 0 4 0 1 2 0 9 7 3 1
2022/202314 13 0 0 0 0 0 0 0 0 0 1 0
2023/202417 2 4 6 2 0 2 0 1 0 0 0 0
2024/202555 12 1 2 0 1 8 8 0 2 1 11 9
2025/2026168 16 22 20 22 29 13 15 7 23 1 0 0
Totale 285